The lipophosphoglycan of Leishmania donovani Up-regulates HIV-1 transcription in T cells through the nuclear factor-κB elements

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2881-2888

  Bernier, Richard ^b   Barbeau, Benoît ^b   Tremblay, Michel J ^a   Olivier, Martin ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPHOSPHOGLYCAN;

AMINO ACID SEQUENCE; ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA DONOVANI; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CALCIUM; GLYCOSPHINGOLIPIDS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; LEISHMANIA DONOVANI; NF-KAPPA B; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0032520772     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Barré-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamarel, T. Gruest, C. Dauguet, B. C. Axler, F. Brun-Vézinet, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868.
2. Popovic, M., M. G. Sangadharan, E. Read, and R. C. Gallo. 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497.
3. McDougal, S. J., J. K. A. Nicholson, G. D. Cross, S. P. Cort, M. S. Kennedy, and A. C. Mawle. 1986. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J. Immunol. 137:2937.
4. Klatzmann, D., F. Barré-Sinoussi, M. T. Nugeyre, C. Dauguet, E. Vilmer, C. Griscelli, F. Brun-Vézinet, C. Rouzioux, J.-C. Gluckman, J.-C. Chermann, and L. Montagnier. 1984. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225:59.
5. Dalgleish, A. G., P. C. L. Beverly, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763.
6. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617.
7. Melbye, M., R. J. Biggar, P. Ebbesen, C. Nealand, J. J. Goedert, V. Faber, I. Lorenzen, J. P. Skinh, R. C. Gallo, and W. A. Blattner. 1986. Long-term seropositivity for HTLV-III in homosexual men without the acquired immunodeficiency syndrome: development of immunological and clinical abnormalities: a longitudinal study. Ann. Intern. Med. 104:496.
8. Fauci, A. S. 1988. Immunopathogenic mechanisms of human immunodeficiency virus (HIV) infection. In Human Retroviruses. Cancer, and AIDS: Approaches to Prevention and Therapy. Alan R. Liss, New York, p. 187.
9. Davis, M. G., S. C. Kenney, J. S. Pagano, and E. S. Huang. 1987. Immediate early gene region of HCMV trans-activates the promoter of HIV. Proc. Natl. Acad. Sci. USA 84:8642.
10. Gendelman, H. E., W. Phelps, L. Feigenbaum, J. M. Ostrove, A. Adachi, P. M. Howley, G. Khoury, H. S. Ginsberg, and M. A. Martin. 1986. Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA 83:9759.
11. Seto, S., T. S. Benedict-Yen, B. M. Peterlin, and J. H. Ou. 1988. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA 85:8286.
12. Wachsman, W., A. J. Cann, J. L. Williams, D. J. Slamon, L. Souza, N. P. Shah, and I. S. Y. Chen. 1987. HTLV X gene mutants exhibit novel transcriptional regulatory genes. Science 235:674.
13. Wang, J., C. Jones, M. Norcross, E. Bohnlein, and A. Razzaque. 1994. Identification and characterization of a HHV-6 gene segment capable of transactivating the HIV-1 LTR in an Sp1 binding site dependent manner. J. Virol. 68:1706.
14. Kenney, S., J. Kamine, D. Markovitz, R. Fenrick, and J. Pagano. 1988. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 85:1652.
15. Mann, D. L., S. Gartner, F. Le Sarre, M. Buchow, and M. Popovic. 1990. HIV-1 transmission and function of virus-infected monocytes/macrophages. J. Immunol. 144:2152.
16. Musihi, K. N., W. Lange, and B. Rohde-Schulz. 1990. Exacerbation of human immunodeficiency virus infection in promonocytic cells by bacterial immunomodulators. J. Acquired Immune Defic. Syndr. 3:200.
17. Shattock, R., J. S. Friedland, and G. E. Griffin. 1994. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells. J. Acquired Immune Defic. Syndr. 7:727.
18. Zhang, Y., K. Nakata, M. Weiden, and W. N. Rom. 1995. Mycobacterium tuberculosis enhances human immunodeficiency virus type-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Invest. 95:2324.
19. Daley, C. L., P. M. Small, G. F. Schecter, G. Schoolnik, R. A. McAdam, W. R. Jacobs, and P. C. Hopewell. 1992. An outbreak of tuberculosis with acceleration progression among persons infected with HIV-1. N. Engl. J. Med. 148:1292.
20. + lymphocyte count in African patients co-infected with HIV and tuberculosis. N. Engl. J. Med. 326:231.
21. 2-microglobulin in HIV-1-associated tuberculosis. J. Exp. Med. 177:1511.
22. Tremblay, M., M. Olivier, and R. Bernier. 1996. Leishmania and the pathogenesis of HIV infection. Parasitol. Today 7:257.
23. Fillola, G., X. G. Corberand, P. F. Laharrague, H. Levenes, P. Massip, and P. Recco. 1992. Peripheral intramonocytic leishmaniasis in an AIDS patient. J. Clin. Microbiol. 30:3284.
24. Jeannel, D., P. Tuppin, G. Bruckler, M. Danis, and M. Gentilini. 1989. Leishmaniasis in France. Lancet 2:804.
25. Alvar, J. J., J. Verdejo, A. Osuna, and R. Nàjera. 1987. Visceral leishmaniasis in a patient seropositive for HIV. Eur. J. Clin. Microbiol. 6:604.
26. Fernandez-Guerrero, M. L., J. M. Aguido, L. Buzon, B. C., C. Montalban, and T. Martin. 1987. Evidence that the major surface protein of three Leishmania species are structurally related. Am. J. Med. 83:1098.
27. Zijlstra, E. E., A. M. El-Hassan, A. Ismael, and H. W. Ghalib. 1994. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 51:826.
28. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331:280.
29. Jeronimo, S. M. B., R. M. Oliveira, and S. Mackay. 1994. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans. R. Soc. Trop. Med. Hyg. 88:386.
30. Marty, P., Y. Le Fichoux, F. Pratlong, and M. Gari-Toussaint. 1994. Human visceral leishmaniasis in Alpes-Maritimes. France: epidemiological characteristics for the period 1985-1992. Trans. R. Soc. Trop. Med. Hyg. 88:33.
31. Bernier, R., S. J. Turco, M. Olivier, and M. Tremblay. 1995. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania. J. Virol. 69:7282.
32. Turco, S. J., and A. Descoteaux. 1992. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46:65.
33. Handman, E., L. F. Schnur, T. W. Spithill, and G. H. Mitchell. 1986. Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages. J. Immunol. 137:3608.
34. Cordova-Aguilar, E., J. Chinen, L. Donehower, D. E. Lewis, and J. W. Belmont. 1994. A sensitive reporter cell line for HIV-1 tat activity. HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10:295.
35. Weiss, A., J. Imboden, D. Shoback, and J. Strobo. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 81:4169.
36. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-I carrying MT-2 and MT-4 and application in a plaque assay. Science 229:563.
37. + cell model of chronic infection. J. Virol. 65:4645.
38. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565.
39. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238:800.
40. Henderson, A. J., X. Zou, and K. L. Calame. 1995. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337.
41. Sun, S.-H., J. Elwood, and W. C. Greene. 1996. Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16:1058.
42. Turco, S. J., M. A. Wilkerson, and D. R. Clauson. 1984. Expression of an unusual acidic glycoconjugate in Leishmania donorani. J. Biol. Chem. 259:3883.
43. Bérubé, P., B. Barbeau, R. Cantin, R.-P. Sékaly, and M. Tremblay. 1996. Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 70:4009.
44. Easterbrook, M. D., M. H. Levy, K. M. Gomez, S. J. Turco, R. M. Epand, and K. L. Rosenthal. 1995. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J. AIDS Hum. Retroviruses 10:496.
45. Toison, D. L., S. J. Turco, and T. W. Pearson. 1990. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect. Immun. 58:3500.
46. Andrews, N. C., and D. V. Faller. 1990. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
47. Schnittman, S. M., M. C. Psallidopoulos, H. C. Lane, L. Thompson, M. Baseler, F. Massari, C. H. Fox, N. P. Salzman, and A. S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305.
48. McNeely, T. B., and S. J. Turco. 1990. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J. Immunol. 144:2745.
49. Lippe, C., and C. Ardizzone. 1991. Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL12330A and SQ22536. Comp. Biochem. Physiol. 99:209.
50. Olivier, M., K. G. Baimbridge, and N. E. Reiner. 1992. Inhibition of N-formyl-methionyl-leucyl-phenylalanine-induced stimulus-response coupling in monocytes infected with Leishmania: evidence for a defect in agonist-induced calcium release. J. Immunol. 148:1188.
51. Nabel, G. J., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711.
52. Laughlin, M. A., G. Y. Chang, J. W. Oakes, F. Gonzalez-Scarano, and R. J. Pomerantz. 1995. Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-κB. J. Acquired Immune Defic. Syndr. 9:332.
53. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956.
54. de Gorgolas, M., and M. A. Miles. 1994. Visceral leishmaniasis and AIDS. Nature 372:33.
55. Alvar, J. 1994. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol. Today 10:160.
56. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.
57. Lewis, R. S., and M. D. Cahalan. 1995. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 13:623.
58. Barbeau, B., R. Bernier, N. Dumais, G. Briand, M. Olivier, R. Faure, B. I. Posner, and M. Tremblay. 1997. Activation of HIV-1 LTR transcription and virus replication via NF-κB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds. J. Biol. Chem. 272:12968.
59. Frantz, B., E. Nordby, G. Bren, N. Steffan, C. Paya, R. Kincaid, M. Tocci, S. O'Keefe, and E. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD-3 an inhibitor of NF-κB. EMBO J. 13:861.
60. Clouse, K. A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A. S. Fauci, and T. M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:431.
61. Pomerantz, R. J., D. Trono, M. B. Feinberg, and D. Baltimore. 1990. Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61:1271.
62. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974.
63. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253.
64. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
65. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211.
66. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540.
67. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB proteolysis by site-specific, signal induced phosphorylation. Science 267:1485.
68. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678.
69. Shirakawa, F., and S. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and PKC. Mol. Cell. Biol. 9:2424.
70. Grilli, M., J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
71. Hohashi, N., T. Hayashi, N. Fusaki, M. Takeuchi, M. Higurashi, T. Okamoto, K. Semba, and T. Yamamoto. 1995. The protein tyrosine kinase Fyn activates transcription from the HIV promoter via activation of NFκB-like DNA-binding proteins. Int. Immunol. 7:1851.
72. Tolson, D. L., S. J. Turco, R. P. Beecroft, and T. W. Pearson. 1989. Immunochemical and cell surface arrangement of the Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol. Biochem. Parasitol. 35: 109.
73. Harper, M. E., L. M. Marselle, R. C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83:772.
74. Russell, D. G., and P. Talamas-Rohana. 1989. Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today 10:328.
75. Weiss, R. A. 1993. How does HIV cause AIDS? Nature 260:1274.
76. Pantaleo, G., C. Graziosi, and A. S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327.
77. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183.